Clinical Considerations of the Treatment of Laser Photocoagulation on Central Serous Chorioretinopathy.
- Author:
Sung Kyu KIM
1
;
Byung Joo SONG
Author Information
1. Department of Ophthalmology, School of Medicine, Hanyang University, Seoul, Korea.
- Publication Type:Original Article
- MeSH:
Angiography;
Bruch Membrane;
Central Serous Chorioretinopathy*;
Choroid;
Female;
Fluorescein;
Humans;
Incidence;
Korea;
Light Coagulation*;
Male;
Ophthalmology;
Seoul;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
1978;19(1):23-27
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Laser photocoagulation is a valuable method in treatment of central serous chorioretinopathy. One hundred and sixty patients with central serous chorioretinopathy were analysed with regard to sex, age, affected eye. initial visual acuity, frequency of laser photocoagulation and result and visual acuity after treatment with AO Laser photocoagulator, between May 1, 1973 and December 31, 1976 at the department of ophthalmology, Hanyang University Hosphital in Seoul Korea. By means of fluorescein fundus angiography all patients in this study were found to have choroidal abnormalities associated with serous leakage across Bruch's membrane. The results were as follow: 1. Central serous retinopathy shows a marked predilection for male. The sexual distribution in this paper revealed 146 males (91.25%) and 14 females (8.75%). 2. The age incidence was usually mainly confined to the group between 31 and 40 years of age (48.125%) and 41 and 50 years of age (35.625%). The patients in this study were mainly between 30 and 50 years of age (83.75%). 3. Involvement was almost exclusively unilateral (97.5%). 4. Initial visual acuity was between 0.1~0.3 in 33.75% of the cases and between 0.4~0.6 in 28.75% of the cases. 5. The majority of patients (68.125%) recovered normal vision with one or two sittings of photocoagulation, each sitting composed of 6 to 8 energy pulses producing grade I lesion. 6. During the course of this study normal vision was gained in 56.93% of patients.
